Immucell (ICCC) EBITDA Margin (QoQ) (2010 - 2025)
Immucell (ICCC) EBITDA Margin (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Immucell | 92.01 Mn | 83.15 Mn | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -112.00 |
| Sep 30, 2025 | -847.00 |
| Jun 30, 2025 | -502.00 |
| Mar 31, 2025 | 584.00 |
| Dec 31, 2024 | 1,758.00 |
| Sep 30, 2024 | 229,266.00 |
| Jun 30, 2024 | -229,809.00 |
| Sep 30, 2023 | 1,499.00 |
| Jun 30, 2023 | 2,853.00 |
| Mar 31, 2023 | -2,368.00 |
| Dec 31, 2022 | -2,891.00 |
| Sep 30, 2022 | 317.00 |
| Jun 30, 2022 | -2,554.00 |
| Mar 31, 2022 | 684.00 |
| Dec 31, 2021 | -259.00 |
| Sep 30, 2021 | 52.00 |
| Jun 30, 2021 | 1,387.00 |
| Mar 31, 2021 | 783.00 |
| Dec 31, 2020 | -1,019.00 |
| Sep 30, 2020 | 1,655.00 |